Abstract
In this communication, the effect of acute treatment with lamotrigine (LTG) was investigated on release of main excitatory amino acids (EAA) such as glutamate (Glu) and aspartate (Asp) in the hippocampus of pentylenetetrazol (PTZ)-induced and PTZ-kindled freely moving rats using micro dialysis. The results show that, levels of Glu and Asp significantly increased in the rat hippocampus during the seizure/interical periods for PTZ-status epilepticus (SE) and PTZ-kindled epileptic (EP) rats. The levels of Glu and Asp increased more in EP rat hippocampus than in SE rat hippocampus. After administration of 20 mg/kg LTG, the levels of Glu and Asp significantly decreased in the SE and EP rat hippocampus. The results indicate that: (a) excitability of the PTZ-kindled epileptogenic model is higher than that of the status epilepticus model; (b) the modulation of LTG on the EAA neurotransmitters certainly plays an important role in antiepileptic efficacy, especially in PTZ-kindled epileptic model where the release of EAA was influenced more markedly by acute application of 20 mg/kg LTG.
Similar content being viewed by others
References
Bazil CW (2002) New antiepileptic drugs. Neurol 8:71–81
Kwan P, Sills GJ, Brodie MJ (2001) The mechanism of action of commonly used antiepileptic drugs. Pharmacol Ther 90:21–34
Ferrie CD, Panayiotopoulos CP (1994) Therapeutic interaction of lamotrigine and sodium valproate in intractable myoclonic epilepsy. Seizure 3:157–159
Ferrie CD, Robinson RO, Knott C, Panayiotopoulos CP (1995) Lamotrigine as an add-on drug in typical absence seizures. Acta Neurol Scand 91:200–202
Pisani F, Oteri G, Russo MF, Di Perri R, Perucca E, Richens A (1999) The efficacy of valproate lamotrigine comedication in refactory complex partial seizures: evidence for a pharmacodynamic interaction. Epilepsia 40:1141–1146
Hwang H, Kim H, Kim SH, Kim SH, Lim BC, Chae JH, Choi JE, Kim KJ, Hwang YS (2012) Long-term effectiveness of ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. Brain Dev 34:344–348
Arban R, Maraia G, Brackenborough K, Winyard L, Wilson A, Gerrard P, Large C (2005) Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania. Behav Brain Res 158:123–132
Coderre TJ, Kumar N, Lefebvre CD, Yu JSC (2007) A comparison of the glutamate release inhibition and anti-allodynic effects of gabapentin, lamotrigine, and riluzole in a model of neuropathic pain. J Neurochem 100:1289–1299
Lee HJ, Ertley RN, Rapoport SI, Bazinet RP, Rao JS (2008) Chronic administration of lamotrigine downregulates COX-2 mRNA and protein in rat frontal cortex. Neurochem Res 33:861–866
Chang YYC, Rapoport SI, Rao JS (2009) Chronic administration of mood stabilizers upregulates BDNF and Bcl-2 expression levels in rat frontal cortex. Neurochem Res 34:536–541
Cunningham MO, Jones RSG (2000) The anticonvulsant, lamotrigine decreases spontaneous glutamate release but increases spontaneous GABA release in the rat entorhinal cortex in vivo. Neuropharmacol 39:2139–2141
Cunninham MO, Dhillon A, Wood SJ, Jones RS (2000) Reciprocal modulation of glutamate and GABA release may underlie the anticonvulsant effect of phenytoin. Neurosci 95:343–351
Shuaib A, Mahmood RH, Wishart T, Kanthan R, Murabit MA, Ijas S, Miyashita H, Howlett W (1995) Neuroprotective effects of lamotrigine in global ischaemia in gerbils. A histological in vivo microdialysis and behavioural study. Brain Res 702:199–206
Bacher A, Zornow MH (1997) Lamotrigine inhibits extracellular glutamate accumulation during transient global ischaemia in rabbits. Anaesthesiol 86:459–463
Ahmad S, Fowler LJ, Whitton PS (2004) Effects of acute and chronic lamotrigine treatment on basal and stimulated extracellular amino acids in the hippocampus of freely moving rats. Brain Res 1029:41–47
Paraskevas GP, Triantafyllou NI, Kapaki E, Limpitaki G, Petropoulou O, Vassilopoulos D (2006) Add-on lamotrigine treatment and plasma glutamate levels in epilepsy: relation to treatment response. Epilepsy Res 70:184–189
Eriksson A-S, O’Connor WT (1999) Analysis of CSF amino acids in young patients with generalized refractory epilepsy during an add-on study with lamotrigine. Epilepsy Res 34:75–83
Tomczyk T, Haberek G, Zuchora B, Jaroslawska-Zych A, Kowalczyk MS, Wielosz M, Urbanska EM (2007) Enhanced glutamatergic transmission reduces the anticonvulsant potential of lamotrigine but not of felbamate against tonic-clonic seizures. Pharmacological Repor 59:462–466
Lee C-Y, Fu W-M, Chen C–C, Su M-J, Liou H–H (2008) Lamotrigine inhibits postsynaptic AMPA receptor and glutamate release in the dentate gyrus. Epilepsia 49(5):888–897
Doi T, Ueda Y, Nagatomo K, Willmore LJ (2009) Role of glutamate and GABA transportersin development of pentylenetetrazol-kindling. Neurochem Res 34:1324–1331
Hussenet F, Boyet S, Nehlig A (1995) Long-term metabolic effects of pentylenetetrazol -induced status epilepticus in the immature rat. Neuroscience 67(2):455–461
Li Z-P, Zhang X-Y, Lu X, Zhong M-K, Ji Y-H (2004) Dynamic release of amino acid transmitters induced by valproate in PTZ-kindled epileptic rat hippocampus. Neurochem Int 44:263–270
Sherwin A, Robitaille Y, Quesney F, Olivier A, Leblanc R, Feindel W, Andermann E, Gotman J, Andermann F (1988) Exicitatory amino acids are elevated in human epileptic cerebral cortex. Neurology 38:920–923
Janhua NA, Itano T, Kugoh T, Hosokawa K, Nakano M, Matsui H, Hatase O (1992) Familial increase in plasma glutamic aid in epilepsy. Epilepsy Res 11:37–44
Wilson CL, Maidment NT, Ohomer MH, Behnke EJ, Ackerson L, Fried I, Engel J Jr (1996) Comparison of seizure related amino acid release in human epileptic hippocampus versus a chronic, kainite rat model of hippocampal epilepsy. Epilepsy Res 265:245–254
Schroder H, Becker A (1996) The role of glutamate receptors in pentylenetetrazole kindling of rats-a neurochemical study. Neuropharmacology 35:A28
Schroder H, Becker A, Loβner B (1993) Glutamate binding to brain membrane is increased in pentylenetetrazole-kindled rats. J Neurochem 60:1007–1011
Schroder H, Becher A, Schroder V, Hollt V (1999) 3H-L-glutamate binding and K+-stimulated 3H-D-aspartate release from hippocampal tissue during the development of pentylenetetrazol kindling in rats. Pharmacol Biochem Behav 62:349–352
Ekonomou A, Angelatou F (1999) Upregulation of NMDA receptors in hippocampus and cortex in the pentylenetetrazol-induced “kindling” model of epilepsy. Neurochem Res 24:1515–1522
Hamberger A, Nystrom B, Larsson S, Silfvenius H, Nordborg C (1991) Amino acids in the neuronal microenvironment of focal human epileptic lesions. Epilepsy Res 9:32–43
Carlson H, Ronne-Engstrom E, Ungerstedt U, Hillered L (1992) Seizure related elevations of extracellular amino acids in human focal epilepsy. Neurosci Lett 140:30–32
During MJ, Spencer DD (1993) Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet 341:1607–1610A
Giorgi O, Orlandi M, Lecca D, Corda MG (1991) MK-801 prevents chemical kindling induced by pentylenetetrazol in rats. Eur J Pharmacol 193:363–635
Sayin U, Cengiz S, Altug T (1993) Vigabatrin as an anticonvulsant against pentylenetetrazole seizures. Pharmacol Res 28:325–331
da Silva LF, Pereira P, Elisabetsky E (1998) A neuropharmacological analysis of PTZ-induced kindling in mice. Gen Pharmac 31:47–50
Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65:1–105
Chapman AG (2000) Glutamate and epilepsy. J Nutr 130:1043S–1045S
Chao X-D, Fei F, Fei Z (2010) The role of excitatory amino acid transporters in cerebral ischemia. Neurochem Res 35:1224–1230
White HS, Wolf HH, Woodhead JH, Kupferberg HJ (1998) The National Institutes of Health Anticonvulsant Drug Development Program: screening for efficacy. In: French J, Leppik I, Dichter MA (Eds.), Antiepileptic Drug Development. Advancesin Neurology vol. 76. Lip-pincott-Raven, Philadelphia, pp. 29–39
Lees G, Leach MJ (1993) Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamactil) using primary neurological cultures from rat cortex. Brain Res 612:190–199
Wang SJ, Sibra TS, Gean PW (2001) Lamotrigine inhibition of glutamate release from isolated cerebrocortical nerve terminals (synaptosomes) by suppression of voltage-activated calcium channel activity. Neuro Report 12:2255–2258
Das A, McDowell M, O’Dell MC, Busch ME, Smith JA, Ray SK, Banik NL (2010) Post-treatment with voltage-gated Na+ channel blocker attenuates kainic acid-induced apoptosis in rat primary hippocampal neurons. Neurochem Res 35:2175–2183
Waldmeier PC, Baumann PA, Wick P, Feldtrauer JJ, Stierlin C, Scmutz M (1995) Similar potency of carbamazepine, oxcarbazepine and lamotrigine in inhibiting the release of glutamate and other neurotransmitters. Neurology 45:1907–1913
Afanas’ev I, Kudrin V, Rayevsky KS, Varga V, Saransaari P, Oja SS (1999) Lamotrigine and carbamazepine affect differentially the release of D-[3H]aspartate from mouse cerebral cortical slices. Neurochem Res 24:1153–1159
Zachar G, Wagner Z, Tabi T, Balint E, Szoko E, Csillag A (2012) Differential changes of extracellular aspartate and glutamate in the striatum of domestic chicken evoked by high potassium or distress: an in vivo microdialysis study. Neurochem Res 37:1730–1737
Acknowledgments
This work was financially supported by the Chinese 973 Project (No. 2010CB933903), the Natural Science Foundation of China (NO. 60971045), Hunan Science and Technology Projects (NO. 2012SK3105), the Natural Science Foundation of Hunan Province, China (NO. 12JJ6060), the Research Foundation of Education Bureau of Hunan Province, China (NO. 11A030).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Deng, Y., Wang, M., Wang, W. et al. Comparison and Effects of Acute Lamotrigine Treatment on Extracellular Excitatory Amino Acids in the Hippocampus of PTZ-Kindled Epileptic and PTZ-Induced Status Epilepticus Rats. Neurochem Res 38, 504–511 (2013). https://doi.org/10.1007/s11064-012-0942-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-012-0942-7